Azenta, Inc. (AZTA)

Market Cap	2.06B
Revenue (ttm)	656.32M
Net Income (ttm)	-164.17M
Shares Out	45.57M
EPS (ttm)	-3.09
PE Ratio	n/a
Forward PE	105.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,914,547
Open	45.47
Previous Close	45.53
Day's Range	44.83 - 46.39
52-Week Range	38.82 - 69.16
Beta	1.48
Analysts	Buy
Price Target	63.60 (+40.83%)
Earnings Date	Nov 12, 2024

About AZTA

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segmen...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Feb 1, 1995
• Employees: 3,500
• Stock Exchange: NASDAQ
• Ticker Symbol: AZTA
• Website: https://www.azenta.com

Financial Performance

In 2024, Azenta's revenue was $656.32 million, a decrease of -1.32% compared to the previous year's $665.07 million. Losses were -$164.17 million, 1051.5% more than in 2023.

Analyst Forecast

According to 5 analysts, the average rating for AZTA stock is "Buy." The 12-month stock price forecast is $63.6, which is an increase of 40.83% from the latest price.

Price Target

$63.6

(40.83% upside)

Analyst Consensus: Buy